Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06618521Completed
Randomised, open-label trial in gestational hypertension (GH) (3 arms), sponsored by Cairo University. Primary endpoints: Measurement of mean arterial blood pressure at 12 weeks, Assessment of serum triglycerides level at 12 weeks and 3 more. Started Sep 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06618521.